Biohaven (BHVN) Shares Outstanding (2021 - 2026)

Biohaven (BHVN) posted Shares Outstanding (Entity) of $150.5 million for Q1 2026, up 39.84% sequentially from $107.6 million in Q4 2025, and up 47.41% YoY from $102.1 million in Q1 2025.

Biohaven (BHVN) Shares Outstanding (2021 - 2026) Analysis & Trends

Biohaven has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $150.5 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 47.41% year-over-year to $150.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.5 million (up 47.41% YoY) and the FY2025 annual result came in at $107.6 million, up 6.33% from the prior year.
  • Shares Outstanding (Entity) improved to $150.5 million in Q1 2026 per BHVN's latest filing, from $107.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $150.5 million in Q1 2026 and troughed at $39.4 million in Q3 2022.
  • A 5-year average of $81.8 million and a median of $81.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) changed 0.0% in 2022, then jumped 81.3% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $44.7 million in 2022, then surged by 81.3% to $81.1 million in 2023, then rose by 24.79% to $101.2 million in 2024, then advanced by 6.33% to $107.6 million in 2025, then jumped by 39.84% to $150.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $150.5 million, $107.6 million, and $105.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Biohaven 2.21 Bn 1.94 Bn - 150.64 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 150.64 Mn
Mar 31, 2026 147.62 Mn
Dec 31, 2025 107.62 Mn
Sep 30, 2025 105.82 Mn
Jun 30, 2025 102.37 Mn
Mar 31, 2025 101.94 Mn
Dec 31, 2024 91.23 Mn
Sep 30, 2024 94.37 Mn
Jun 30, 2024 87.77 Mn
Mar 31, 2024 81.60 Mn
Dec 31, 2023 71.20 Mn
Sep 30, 2023 68.32 Mn
Jun 30, 2023 68.25 Mn
Mar 31, 2023 68.21 Mn
Dec 31, 2022 44.74 Mn
Sep 30, 2022 39.37 Mn
Jun 30, 2022 39.38 Mn
Mar 31, 2022 39.38 Mn
Dec 31, 2021 39.38 Mn
Sep 30, 2021 39.37 Mn